Finance

Lists
000963:SHE
Huadong Medicine Co., Ltd.
26,25 CNY
-0,19%
(-0,050) 1D
16 ოქტ, 15:04:24 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000963...
Open
26,43 CNY
High
26,90 CNY
Low
25,98 CNY
Mkt. cap
46,61 მლრდ.
Avg. vol.
13,27 მლნ.
Volume
15,87 მლნ.
Dividend
3,54%
Quarterly dividend
0,23 CNY
Ex-dividend date
18 სექ. 2026
P/E ratio
13,27
52-wk high
43,78 CNY
52-wk low
25,63 CNY
EPS
1,98 CNY
Shares outstanding
1,75 მლრდ.
No. of employees
19 ათ.
Open
26,43 CNY
High
26,90 CNY
Low
25,98 CNY
Mkt. cap
46,61 მლრდ.
Avg. vol.
13,27 მლნ.
Volume
15,87 მლნ.
Dividend
3,54%
Quarterly dividend
0,23 CNY
Ex-dividend date
18 სექ. 2026
P/E ratio
13,27
52-wk high
43,78 CNY
52-wk low
25,63 CNY
EPS
1,98 CNY
Shares outstanding
1,75 მლრდ.
No. of employees
19 ათ.
News stories
From web sources and news partners
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19,1 ათ.
Founded31 მარ. 1993
Headquarters-
SectorHealth care provider
Websiteeastchinapharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
10,99 მლრდ.
10,95 მლრდ.
11,18 მლრდ.
10,88 მლრდ.
Cost of goods sold
7,39 მლრდ.
7,79 მლრდ.
7,39 მლრდ.
7,45 მლრდ.
Cost of revenue
7,39 მლრდ.
7,79 მლრდ.
7,39 მლრდ.
7,45 მლრდ.
Research and development expenses
507,92 მლნ.
245,56 მლნ.
350,37 მლნ.
396,72 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,93 მლრდ.
1,99 მლრდ.
2,19 მლრდ.
1,92 მლრდ.
Operating expense
2,33 მლრდ.
2,51 მლრდ.
2,60 მლრდ.
2,41 მლრდ.
Total operating expenses
9,72 მლრდ.
10,31 მლრდ.
9,99 მლრდ.
9,86 მლრდ.
Operating income
1,27 მლრდ.
642,86 მლნ.
1,19 მლრდ.
1,03 მლრდ.
Other non operating income
-72,11 მლნ.
53,61 მლნ.
-4,09 მლნ.
-10,61 მლნ.
EBT including unusual items
1,07 მლრდ.
753,84 მლნ.
1,19 მლრდ.
1,02 მლრდ.
EBT excluding unusual items
1,19 მლრდ.
723,38 მლნ.
1,19 მლრდ.
1,01 მლრდ.
Income tax expense
130,93 მლნ.
84,85 მლნ.
195,03 მლნ.
176,07 მლნ.
Effective tax rate
12,24%
11,26%
16,36%
17,28%
Other operating expenses
-105,72 მლნ.
224,00 მლნ.
58,88 მლნ.
63,39 მლნ.
Net income
933,09 მლნ.
666,42 მლნ.
1,00 მლრდ.
858,57 მლნ.
Net profit margin
8,49%
6,09%
8,96%
7,89%
Earnings per share
0,54
-
-
-
Interest and investment income
26,71 მლნ.
12,97 მლნ.
20,16 მლნ.
18,36 მლნ.
Interest expense
-33,70 მლნ.
-
-19,18 მლნ.
-12,03 მლნ.
Net interest expenses
-6,99 მლნ.
12,97 მლნ.
979,40 ათ.
6,33 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,46 მლრდ.
873,59 მლნ.
1,43 მლრდ.
1,29 მლრდ.
Gain or loss from assets sale
-6,20 მლნ.
-2,26 მლნ.
-
-1,42 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები